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Abstract
 Obtaining genuine informed consent from research participantsBackground:
in developing countries can be difficult, partly due to poor knowledge about
research process and research ethics. The situation is complicated when
conducting genomic research on a disease considered familial and a reason for
stigmatisation.
 We used a Rapid Ethical Appraisal tool to assess local factors thatMethods:
were barriers to getting genuine informed consent prior to conducting a genetic
study of podoconiosis (non-filarial elephantiasis) in two Zones of Ethiopia. The
tool included in-depth interviews and focus group discussions with patients,
healthy community members, field workers, researchers/Institutional Review
Board (IRB) members, elders, religious leaders, and podoconiosis
administrators who work closely with patients.
 Most patients and healthy community members did not differentiateResults:
research from routine clinical diagnosis. Participants felt comfortable when
approached in the presence of trusted community members. Field workers and
podoconiosis administrators preferred verbal consent, whereas the majority of
patients and healthy community members prefer both verbal and written
consent. Participants better understood genetic susceptibility concepts when
analogies drawn from their day-to-day experience were used. The type of
biological sample sought and gender were the two most important factors
affecting the recruitment process. Most researchers and IRB members
indicated that reporting incidental findings to participants is not a priority in an
Ethiopian context.
 Understanding the concerns of local people in areas whereConclusions:
research is to be conducted facilitates the design of contextualized consent
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 research is to be conducted facilitates the design of contextualized consent
processes appropriate for all parties and will ultimately result in getting genuine
consent.
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Introduction
Informed consent is a prerequisite for conducting ethical research 
on human participants. It is considered valid when participants 
(i) receive appropriate and comprehensive information, (ii) under-
stand essential aspects of the research, (iii) voluntarily participate 
without any form of coercion, and finally (iv) agree to participate 
by giving either written or verbal consent.
Even though these principles are endorsed by many international 
and national ethics guidelines, the reality is far from this, and 
there is still a gap in achieving genuine informed consent, 
especially in studies conducted in developing countries. A meta-
analysis of 21 studies conducted in Africa indicated that com-
prehension of key concepts (for example, randomization and 
placebo) differed significantly among participants, and “thera-
peutic misconception” is a very common issue1. Therapeutic 
misconception occurs when participants do not understand the 
distinction between research and clinical care, and believe the 
purpose of their participation is to get some form of treatment 
rather than to generate new data. Some of the reasons for such mis-
conceptions are high disease burden, poor access to health care, 
and low literacy levels in these countries1. Another issue affect-
ing the consent process is the extent to which a community or 
family interferes with the autonomous decision-making capacity 
of an individual. Western ethics guidelines place a huge emphasis 
on autonomous decision-making, and this may be contrary to the 
decision-making practice in most rural African settings2,3.
The situation is further complicated in obtaining informed consent 
for genomic research due to the broad and unexpected nature of 
results generated from such studies. For example, in conducting 
sequencing and genotyping studies, researchers might discover 
genetic variants, which increase the risk of developing certain 
diseases. Such findings are medically relevant and are termed 
as ‘incidental findings’. In Africa, the rapid decline in sequenc-
ing cost and advances in technologies has prompted scientists to 
undertake genomic studies, and it is essential to develop guide-
lines on how to manage incidental findings in order to conduct 
ethical research.
In the past few years, many studies have promoted the need to 
contextualize the informed consent process to develop one that 
is ethically sound and culturally sensitive4,5. One tool recently 
employed to explore barriers to ethical conduct of research and 
tailor the consent process to the local context is Rapid Ethical 
Appraisal (REA)2,3,6–8. Similar to traditional qualitative studies, 
REA use in-depth interviews (IDIs), focus-group discussions 
(FGDs) and observation to collect data from key community 
informants. However, it is faster and more cost-effective in gen-
erating insights and reconciling western ethical standards with 
the context of developing world research settings6,9.
The validity and feasibility of REA has been assessed recently in 
Ethiopia and was found to be relevant and acceptable in explor-
ing social and cultural issues affecting the ethical conduct of 
research9,10. Using this tool, for example, Tekola et al., found 
that podoconiosis patients in Wolaita, Southern Ethiopia, were 
afraid to participate in a genetic study for fear that the study might 
confirm the hereditary nature of the disease and fuel the existing 
social stigma11. Studies in Cameroon also identified a number of 
issues regarding how to approach and obtain informed consent 
from participants involved in podoconiosis genetic research2,7.
Even though the tool has been employed previously to explore 
ethical issues in Ethiopia3,11, issues identified in Wolaita might not 
be applicable to other Ethiopian populations that differ in their 
social and community structure. The purpose of this REA study 
was therefore to explore barriers to getting genuine informed 
consent prior to enrolling participants in the genome-wide 
association study (GWAS) of podoconiosis in East Gojjam and 
East Wellega Zones of Ethiopia.
Methods
Ethical consideration
Ethical approval was obtained from the Armauer Hansen 
Research Institute (AHRI)/All Africa Leprosy and Tuberculo-
sis Rehabilitation and Training Centre (ALERT) Ethics Review 
Committee, Addis Ababa, Ethiopia (registration number 
PO20/12) and the National Research Ethics Review Committee, 
Addis Ababa, Ethiopia (reference number 3.10/577/06) before 
conducting the study. Permission was also obtained from the 
Oromia and Amhara regional health bureaus. We obtained ver-
bal consent instead of written consent as we were exploring the 
preferred method of consent documentation in our study area.
Study area and settings
This study was conducted from February to April 2014 in East 
Gojjam and East Wellega Zones (Figure 1) of North and North-
Western Ethiopia, respectively, prior to enrolling participants 
to the podoconiosis genetic association study. This study aimed 
to validate the association between podoconiosis and genetic 
variants in the HLA region using DNA from saliva sample12 in 
Wolaita, Amhara and Oromo ethnic groups in Ethiopia. Amharic 
and Afaan Oromo are the most widely spoken languages in 
East Gojjam and East Wellega (99% and 88% of the population, 
respectively). The majority of the population in these two Zones 
are subsistence farmers living in rural areas (92.28% in East 
Wellega and 90.08% in East Gojjam). The prevalence of podoco-
niosis among individuals aged 15 years and above was reported 
to be 3.3% in Gojjam13 and 2.8% in Wellega14.
Study design and participants
We conducted IDIs and FGDs with podoconiosis patients, 
healthy community members, podoconiosis administrators, elders/
religious leaders, field workers, kebele (the smallest administra-
tive unit in Ethiopia) leaders, and researcher/IRB members to 
explore their views on the consent process. The FGDs were com-
prised of single-sex adults each containing 5 to 7 individuals. 
Participants were chosen purposively based on their ability to 
discuss the issues openly and inform the phenomenon under 
investigation. Participants were chosen in consultation with field 
workers of the International Orthodox Christian Charities (Debre 
Markos, Gojjam) and the Ethiopian Catholic Church Clinics 
(Nekemte, Wellega). The field workers are experienced (>3 years 
of experience working in the community) and provide treatment 
and rehabilitation services to the communities affected by the 
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disease. Recruitment and interviewing continued until informa-
tion saturation was reached and no further ideas were generated 
from additional interviews.
Data collection
Guide questions were prepared for each interviewee group in 
English (Supplementary File 1), and were then translated into 
Amharic and Afaan Oromo by an independent person. The inter-
views were back-translated by an investigator (ZA) who was 
not involved in conducting the interviews. With the exception 
of three interviews conducted in English (with podoconiosis 
administrators), all other interviews in East Wellega were con-
ducted in Afaan Oromo. All the interviews in East Gojjam were 
conducted in Amharic. The interviews were conducted by the 
principal investigator (TTG) and the two co-investigators (FTA, 
GT), who had experience in conducting qualitative research.
Data analysis
The audio of the interviews were transcribed and translated to 
English by the principal investigator and two co-investigators, 
and checked for inconsistencies. Transcripts were imported to 
NVivo 10 software (QSR International) and coded independ-
ently by the PI and the co-investigators. Thematic analysis was 
then used to identify patterns and themes using a conceptual 
framework described in previous studies2,3,7,11.
Results
In total, 43 IDIs and 5 FGDs were conducted (Table 1) with 31 
men and 20 women from East Gojjam, and 16 men and 8 women 
from East Wellega. The age of respondents ranged from 18 to 68.
The issues that arose from the analysis were grouped into the fol-
lowing themes: perceptions towards health research and informed 
consent, preparation of information sheet and consent form, 
approaching the community, information provision, assessing 
comprehension, decision-making, recruitment, consent taking, and 
return of incidental findings.
Perceptions on health research
The majority of healthy community members and patients in 
the rural areas had incorrect or no understanding about research. 
They described research as a routine health care activity with the 
goal of providing treatment for their illness. Few could correctly 
distinguish between the two concepts.
“I believe research is a tool to maintain our health. We know 
our health status after participating in a research.” (Patient 9, 
Gojjam).
“I don’t have any idea about this [research].” (Patient 2, Wellega).
Figure 1. Map of Ethiopia showing the two study areas (East Gojjam and East Wellega). Wolaita, where the first Rapid Ethical Appraisal 
study was conducted, is shown for reference.
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“Research is used to increase new knowledge, whereas diagnosis is 
to find the disease.” (Patient 7, Gojjam).
Some participants’ responses implied that research involving 
questionnaire-based data collection might be confused with aid 
eligibility assessment or criminal investigation.
“Nobody knows what it is, but they [the community] recognize, 
if new face comes with questionnaire, whether that is short or 
long, something will come after a while. That is their expectation.” 
(Podoconiosis administrator 2, Wellega).
The misconception regarding research and criminal investigation/
diagnosis arise from the use of Amharic words that sound the same 
but have different meanings - a term referred as homophones.
“As a result of their past political and social experiences, the 
society differ in their understanding of words that are used to 
describe research, and care must be taken in this regard. For 
example, they may associate research with crime, police investiga-
tion and being a witness for someone.” (Podoconiosis administrator 
2, Gojjam).
When asked to participate in research (in Amharic “Meremer”), 
some participants confused this term with another Amharic term 
“Mermera” which can imply either clinical diagnosis or police 
investigation. Moreover, research-involving drawing blood may 
be mistaken for screening for diseases, particularly HIV/AIDS.
“When you tell them that you are doing research, all people think 
it is HIV testing. It is not clear to them. They take research and 
diagnosis as the same.” (Elders/religious leaders 3, Gojjam).
“Research is used for identification of diseases during illness and 
for checking oneself (HIV-testing). People go to health facilities 
to get tested for HIV.” (Elders/religious leaders 1, Wellega).
Perceptions on informed consent for health research
There was unanimous agreement among all researcher/IRB 
members and field workers interviewed that informed consent is 
a tool to communicate the study to potential participants and is 
essential to maintain quality of research.
“Many research participants could be vulnerable due to lack of 
knowledge; even educated people can sometimes be vulnerable. So, 
the information sheet is a tool to describe the basic of the study in 
an easy language.” (Researcher/IRB member 2).
“People usually give genuine answer when they are relaxed and 
free. They might not give you genuine answer if they are forced or 
coerced.” (Researcher/IRB member 6).
“Informed consent is a process of obtaining permission from our 
participants.” (Researcher/IRB member 1).
Preparation of consent form and information sheet
Participants stressed the need to express study information in a 
simple and precise manner using few technical terms.
“Some researchers don’t know what kind of information they pro-
vide. They put everything research participants do not necessarily 
have to know. I received 20-page information sheet and consent 
form when I worked as ethics secretariat. It is amazing. It shows 
lack of confidence” (Researcher/IRB member 4).
Patients and healthy community members wanted to be told about 
the objectives, implications and benefits of the study, as well as 
cause and prevention of podoconiosis before deciding to partici-
pate in the research. On the other hand, researcher/IRB members 
insisted on a need to inform prospective participants the type of 
study, foreseeable risks, confidentiality, voluntariness, and contact 
details of the principal investigator (s) and ethics committee(s) that 
approved the study. 
“Healthy people will be volunteer if you tell them first about the 
cause of the disease and then what you will do to their saliva 
sample.” (Healthy community member 3, Gojjam).
“I want to be told about the importance of the study to my health.” 
(Podoconiosis patient 3, Wellega).
Table 1. Type and number of interviewees in each group. IDI, in-depth 
interviews; FGD, focus group discussion.
Participant type East Gojjam East Wellega
IDIs FGDs IDIs FGDs
Patients 8 1 (n=6) 5 -
Healthy Community 
Members
1 3 (each n=5, 6, 7) 2 1 (n=7)
Podoconiosis administrators 2 - 3 -
Elders/religious leaders 4 - 2 -
Field Workers 3 - 3 -
Kebele Leaders 2 - 2 -
Researcher/IRB members 7 IDIs
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“Confidentiality should be secured but it is a very difficult issue 
since most often many people are around…You may make an effort 
to keep people out of the hearing distance but in a village setting 
it is often not easy. Then the idea of confidentiality may also be a 
bit different because people have most of their private things in 
public. Is it not?” So, I think that is the most important thing, con-
fidentiality.” (Researcher/IRB member 3).
Some researcher/IRB members suggested doing pre-testing of the 
consent form and information sheet in the study site to assess its 
suitability and appropriateness.
“If participants are from rural areas, the information sheet and 
consent form have to be pretested in advance. Then we can use 
it if they say it is appropriate. Sometimes when I ask participants, 
they ask me back questions saying, “What do you mean by that?” 
So, sometimes you can learn words or phrases from participants 
that you can use to describe certain information.” (Researcher/IRB 
member 5).
Approaching potential study participants
Many participants suggested approaching participants in the 
presence of known and trusted community members, including 
religious and kebele leaders, health extension workers, patient 
association leaders, local NGO staff. Others also mentioned using 
existing governmental or social structures, such as the ‘1-to-5’ 
networking scheme (a government-created structure where one 
member networks with five other people and leads the group to 
discuss societal issues) and Idir (locally established traditional 
self-help financial associations).
“There is a local saying “Yeagerun bere beageru serdo”, which is 
to mean “local problems can be best solved by the local people.” 
…They might be suspicious if you read the information to them, but 
they might not if someone they know reads it in front of them. You 
can ask the kebele administrators to read the consent form in front 
of them.” (Field worker 3, Gojjam).
“… They prefer to see someone whose face is not new to them.” 
(Podoconiosis administrator 2, Wellega).
“The health extension workers are better since it is related to health. 
The people may assume that they are summoned for a government 
meeting if they are called by the kebele administrator.” (Healthy 
community member 2, Gojjam).
“If you want the community at large, Kebele is better. If small 
group is needed, we [the church] can call them.” (Podoconiosis 
administrator 1, Wellega).
There was considerable discussion for and against the involvement 
of health extension workers (HEWs) in approaching community 
members for research. Most participants said that kebele leaders 
are important to confirm credibility of the study and approach 
prospective participants, whereas HEWs would be more appropri-
ate to discuss health-related issues. Some participants, however, 
cautioned against employing HEWs because of their already-
stretched work schedules.
It was indicated that the best time to approach potential partici-
pants is during the dry season, weekends (preferably Sunday) or 
holidays (especially religious holidays) when they are not actively 
engaged in farming activities. 
“You can recruit many people as long as your schedule coincides 
with participants. You have to be very flexible. You may find a 
religious leader working as a farmer, so you can interview him 
under the shade of a tree.” (Researcher/IRB member 3).
Information provision
The local people use the Amharic term “Zer” or “Zer kotero 
meta” to describe hereditary diseases passed across family. Field 
workers and podoconiosis administrators warned that such 
concepts must be explained cautiously so participants do not 
consider podoconiosis as a hereditary disease.
“It is difficult to tell podoconiosis susceptibility concept. We do not 
tell them directly. If we do, they may consider susceptibility as a 
hereditary condition, and this may affect our work.” (Podoconiosis 
administrator 2, Gojjam).
“…Our target was not to put the genetic component of the dis-
ease at the centre of their attention. The community worried and 
think it [podoconiosis] is inherited. As I told you before, we try 
to give them examples and show them that they get the disease 
from the soil and by not wearing proper shoes…So, if somebody 
comes and talks about hereditary nature of podoconiosis, it 
counteracts our efforts. So can’t you put it in a broader sense like 
various ideas where this disease can come from?” (Podoconiosis 
administrator 3, Wellega).
Participants better understood genetic variation and difference in 
disease susceptibility concepts when analogies drawn from their 
day-to-day observations were used. In particularly, many par-
ticipants were familiar with the notion of improved seed yielding 
bigger crops, which proved to be a useful analogy. Podoconiosis 
administrators also mentioned that they pose a question to partici-
pants “why do some people get sick with the common cold and 
some do not despite living in one household?” to explain suscepti-
bility difference in a family. They said a two-way conversation and 
probing is helpful to promote understanding of abstract concepts.
“...We tell them that all their family members do not develop 
common cold at once; some members may and some may not. So 
you can explain the concept of genetic susceptibility this way.” 
(Podoconiosis administrator 2, Gojjam).
“I don’t know how to explain this. It is difficult to me. Maybe a 
good explanation is needed...focusing on the nature of foot sole 
thickness and how the diseases go through family could also help.” 
(Field worker 2, Wellega).
Assessing comprehension
Field workers and podoconiosis administrators suggested to 
assess comprehension by asking open-ended question and said 
that this approach can clear any potential misconceptions about 
the study and enhance participants’ understanding of key study 
information.
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“After you provide information about your study, ask them to tell 
you what they understood from your talk. That way you can assess 
their understanding level.” (Field Worker 1, Gojjam).
“Once you told them about the study in their local language, ask 
them open-ended questions to check if they understand what you 
mean.” (Podoconiosis administrator 1, Gojjam).
“After you explain the study, ask 3 or 4 participants to explain 
to others what you have been saying. This can help others who 
have misunderstood your explanation to catch-up with the group.” 
(Field Worker 2, Gojjam).
Decision-making, recruitment and consent taking
Most participants said that they could decide by themselves as long 
as they are not asked to come repeatedly, cover their own costs, 
stay away from their home for a long time, or are required to use 
family planning methods (a decision that is usually made after 
discussing with their partners). Some also said they reach a deci-
sion on their own if the research benefits their health – further 
evidence that ‘therapeutic misconception’ is common in society.
“The problem is if I am asked to pay a certain fee. So it is better 
if I decide together with my partner.” (Patient 2, Gojjam).
“I don’t think they will discuss with their family. The only time they 
do that is when they are asked to use family planning methods.” 
(Kebele leader 2, Gojjam).
“It depends on the decision to be made. They will definitely dis-
cuss with their family members if, for example, the treatment site 
is far and are asked to stay for 15 days or spend 7 days for foot 
massage. The whole family discuss and debate whether that 
person should go or not, and at the end, the idea accepted by 
most people win.” (Podoconiosis administrator 2, Gojjam).
Several factors that could potentially influence the recruitment 
process were raised and these are listed in Table 2.
We found mixed views regarding the preferred form of consent 
documentation. Field workers and podoconiosis administrators 
preferred verbal consent, whereas the majority of patients and 
healthy community members suggested the use of both verbal 
and written consent to accommodate the needs of literate and 
illiterate participants.
“First, they have to be educated. They sign a consent form 
freely if they understand it well. If they are asked to sign without 
explanation, they may think something bad is done behind them.” 
(Healthy community member 4, Gojjam).
“They think something tangible if it is written and read to them. 
There is a local saying that” what is written on paper and what 
a fool once understands can never be lost or forgotten!” So, they 
want written information.” (Field Worker 2, Wellega).
“Healthy people might be afraid of signing; they might associate 
it with bad experience such as tax or confiscating their property. 
The situation can even be difficult with illiterates. They are 
suspicious and might think what is written on the document and 
what is read for them is different.” (Field Worker 1, Gojjam).
Return of Incidental findings
We finally asked researcher/IRB members to share their views 
about returning incidental findings in an Ethiopian context. 
Incidental findings are medically relevant information encoun-
tered in the course of a study but are beyond the aim of the study 
for which participants originally consented. The majority of 
researcher/IRB members were against disclosing incidental 
findings and felt that “not knowing is better than knowing”, given 
the poor health system in low-income countries.
“There are many severe and disabling conditions, and up to now, 
the health structure hasn’t been very good in addressing these. I 
find it unethical to tell participants they have susceptibility to rare 
cancer, which has no cure.” (Researcher/IRB member 6).
Table 2. Factors affecting recruitment to research.
Factors Description
Gender Some females (especially those that are married) might not be comfortable 
being interviewed alone with a stranger. 
Sample type sough Saliva is preferred over blood and other samples that require invasive collection 
procedures. Some associate blood sampling with HIV testing and sorcery. 
Perception towards local 
government officials 
Individuals who are not happy with local government officials may decline to 
participate in a research. 
Previous exposure to 
research 
Individuals with previous research exposure were not suspicious that their 
samples will be used in sorcery activities. 
Economic status Some people who are economically better might be offended when they are 
offered incentives, whereas those who are not economically strong may decline 
to participate for fear that they will be charged fees. 
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“In a country where we even don’t have enough drugs for 
headache, the disadvantage to know incidental finding weigh more 
than its advantage.” (Researcher/IRB member 5).
A few, however, said that the issue should be decided by 
stakeholders, including the IRB and family members. They all 
agreed, however, to provide participants the option whether they 
would like to receive their incidental finding result, but were 
sceptical if participants, especially those living in rural areas, 
understand the implications of their decision.
“I don’t think it is appropriate and ethical to reveal the result 
[incidental findings] unless the patient expresses their consent.” 
(Researcher/IRB member 4).
“The main difficulty that you will face is explaining incidental 
finding to participants.” (Researcher/IRB member 3).
Discussion
Obtaining genuine informed consent from participants in low-
income countries can be difficult, partly due to poor knowledge 
about research processes and research ethics15. Cultural and social 
values surrounding disease and illness and familiarity with evi-
dence-based research are among the many factors that influence 
the consent process16. Using REA as a tool, we identified a range 
of factors that can act as barriers to gaining genuine consent. We 
subsequently used these findings to design a contextualized con-
sent process for a genomic study of podoconiosis (study completed; 
manuscript currently under preparation). 
Most participants residing in rural areas did not know the dis-
tinction between research and health care and thought they were 
being screened to receive treatment rather than participate in 
research. Therapeutic misconception is common in low-income 
countries1,3,7,17,18, especially in clinical research where providing 
treatment and conducting research are often carried out simulta-
neously19. Researchers conducting studies in such settings must 
assess participants’ motivations for taking part in the research. In 
our main genetic study, we explicitly informed participants that 
we were not affiliated with the local NGOs, which provide 
podoconiosis treatment services to the communities, and employ-
ees of the NGOs who helped us facilitate participant recruitment. 
Similar to findings of Tekola et al.3, trusted individuals are the 
preferred entry point to the community. Community engagement 
and sensitization is critical to gain access, build trust and provide 
study-related information to prospective participants. For example, 
a religious leader spread a rumour that the vaccine used for polio 
immunization was contaminated with anti-fertility substances. This 
negatively impacted on uptake rates and resulted in discontinuation 
of the vaccination campaign20. The campaign was later resumed 
after discussion with the religious leaders and convincing the pop-
ulation that the vaccine was safe and protects people from polio. 
This example highlights the influential role of community leaders 
and the importance of engaging them when conducting community-
based studies or interventions.
Our study indicated that prospective participants need to know 
basic information about the study and did not require detailed 
information to take part in our study. Even though most informa-
tion sheets and consent forms contain the purpose and objective of 
the study, it is important to cover all aspect of the research to help 
participants reach an informed decision. In the context of genomic 
studies, this includes information about the nature of the study, 
privacy, confidentiality, future use of samples and data/sample 
sharing plan. Participants in rural settings might not fully under-
stand some of these concepts and a thorough explanation is 
needed to create awareness. In a study conducted in rural Ghana, 
for example, participants did not completely understand a state-
ment about future use of stored samples, but grasped the idea 
when the concept was broadly explained using familiar exam-
ples, such as that “their left-over samples could be used in future 
studies when new ideas come up”21. Similarly, explaining heredi-
tary concepts and maintaining a balance with transparency 
was challenging but could be done if the community’s understand-
ing is assessed prior to conducting the study.
In our study, we explained genetic susceptibility concepts using 
the common cold analogy described above, saying that individuals 
from the same family differ in their ability to fight infections. Thus, 
simple and real-world examples must be used to describe abstract 
and scientific concepts so that participants can fully comprehend 
the nature of the study in which they agree to participate18,22.
The field workers suggested that probing and checking the level 
of understanding of key study information in a question format 
(rather than using the traditional binary form of assessment, 
e.g., yes/no format) could improve comprehension. Lindegger 
et al. used 4 tools (self-report, checklist, vignettes, and narrative 
measures) to assess comprehension, and higher scores were 
recorded when checklists were used, indicating that the level 
of understanding is dependent on the type of tools used23. The 
method suggested by the field workers needs further evaluation to 
check its appropriateness to the local settings. We did not imple-
ment this suggestion in our work because of resource constraints.
Participants also indicated that the language used to describe 
the research process could affect the consent process. For 
example, some may take the Amharic translation for the English 
word research “Mermer” to mean a police/criminal investigation. 
Words can have different meaning depending on the context and 
settings24, and to avoid confusion, it is recommended to pre-test 
the information sheet and consent form to evaluate its appropri-
ateness in the target population. In our case, we avoided using 
“Mermer” when describing research and used unambiguous 
words (e.g., “Tinat” for research) that reduced the possibility of 
negative interpretation by the community. Such an approach has 
been suggested by Molyneux et al., who studied informed consent 
processes in Kenya25.
Participants had misconceptions linking research with aid and 
expected monetary or in-kind benefits. Even though acceptable 
compensation is appropriate, any available benefits in resource-
limited settings might result in undue influence on participants26,27. 
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We discussed this issue with field workers and podoconiosis 
administrators and they suggested providing soap and other 
sanitary materials to promote foot hygiene, as an alternative to 
monetary compensation. The issue of ‘appropriate’ compensation 
is often controversial and context-specific, and to this end, local 
regulatory authorities (including ethics committees) must work 
with the community and researchers to establish reasonable 
compensation system.
Signing a consent form was found to be acceptable to patients and 
healthy community members and both groups supported the use 
of either written or verbal consent. We chose to document verbal 
consent for the REA study, whereas written consent was used in the 
main genetic study since institutional and national ethics commit-
tees in Ethiopia require written consent when conducting genetic 
studies on humans.
Many factors that could potentially affect participants’ recruitment 
were identified. Among these, gender and type of sample sought 
were considered by field workers and podoconiosis administra-
tors to be the most important. In some communities, cultural prac-
tices negatively influence women’s participation in some types of 
research studies (e.g. sexual health issues)28, and permission might 
be required from their husband to participate in such studies. A 
study conducted in Qatar, for example, indicated that a majority 
of Muslim female participants felt they should not be interviewed 
in a private room with a man and preferred the outpatient waiting 
area where they can be seen in public29. In our genetic study, enrol-
ment was carried out in public places (clinics, schools and kebele 
compounds) and questions that can be considered sensitive were 
not asked. If gender issues are anticipated, however, researchers 
are advised to assess the existing gender norms in their proposed 
study area and design culturally sensitive ways to approach poten-
tial participants (e.g., gender-matching between researchers and 
participants)28.
All participants preferred to give saliva compared to other 
sample types that require invasive collection procedures (e.g., 
blood). Blood sampling is a very sensitive issue in most rural 
African settings25. In a study conducted in Nigeria, for exam-
ple, participants complained their blood could be used in sorcery 
activities30. On the contrary, participants in our settings did not 
associate saliva with sorcery; some were even surprised that their 
saliva sample could be helpful for research or laboratory-based 
diagnosis.
In the past few years, the cost of genome sequencing has plum-
meted dramatically, and this has resulted in an increasing number 
of genomic studies. The ethical, legal and social implications 
(ELSI) of such studies are extensively considered in Western 
countries31, but they are not given much emphasis in Ethiopia as 
the medical application of genetics (e.g., genetic counselling, 
pharmacogenetics, etc.) is not widespread in the country. 
However, Ethiopian scientists are involved in national and 
international collaborative genomic studies (e.g., Human Hered-
ity and Health in Africa project) and a consensus must be reached 
on how to handle the ELSI issues. In our study, we particularly 
raised the issue of incidental findings to researcher/IRB mem-
bers and the majority of them were against disclosing incidental 
findings arguing that there are other health issues (e.g., providing 
child-maternal health care) to which priority must be given. In 
their review, Wright et al., discussed the ethical issues in conduct-
ing large-scale genomic studies in African population32, and they 
indicated that disclosing incidental findings is a complex issue in 
most countries. For example, whose duty is to inform incidental 
findings to research participants? Which results must be returned? 
Some of these issues are philosophical and active debate must 
continue between various stakeholders of the research enterprise 
to come up with a recommendation for the Ethiopian context.
Conclusions
Our study indicated that a ‘one-size fits all’ approach does not work 
when it comes to consent process. As described in Addissie et al. 
(2015), REA might not be required for all studies and the decision 
to employ the tool should be based on many factors, including the 
community where the study is to be conducted, the research topic, 
and the availability of resources9. However, REA is especially 
useful to explore issues in studies where ethical dilemmas are 
anticipated, including randomized clinical trials, studies con-
ducted in research-naïve areas, and research involving sensitive 
topics and vulnerable groups33. Understanding local issues will 
help to design contextualized consent processes appropriate for all 
parties and ultimately in getting genuine consent.
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I have the benefit of having read other reviewers' reports, and will limit my comments.
This is an interesting paper and we would like to thank you for giving us the opportunity to review this
paper. Work that aims to advance the cause of informed consent in the medical research in the rural
African setting is to be welcomed. We appreciate the emphasis placed on context and contextual issues
like the variety of languages. Overall however, there seems to be a disconnect between the introduction,
results and discussion. The abstract and introduction speaks about the genetic research, yet the results
and discussion appear to focus on medical research generally. More reflection on the use of the REA and
its limitations should be incorporated into this paper.
The following are specific comments on the paper.
Introduction
Genomic research raises a number of challenges for the informed consent process and it is not clear why
there is a focus on incidental findings only, particularly as the results speak to a wider range of issues. A
broader discussion of these issues and, in particular, in the African setting would be good.
Methods
The conceptual framework mentioned in the data analysis should be briefly discussed.
Would it not also have been significant to interview traditional healers as well, since many Africans
have to rely on their services, they are often trusted and revered members of rural communities
and their views may be influential in those societies? Should they be involved in research at all, as
has been done with HIV in many settings?
Results
Under researcher/IRB members, does this mean that they are both researchers and IRB
members?
Throughout the results, it is often not clear whether you are referring to health research generally or
podoconiosis. This should be clarified.
At times the differences between researcher/IRB and other groups are discussed, but this is not
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 At times the differences between researcher/IRB and other groups are discussed, but this is not
consistent e.g. perceptions on informed consent for health research contains views of
IRB/researchers only. These divergent views (if any) should be included. If consistent, this should
also be made clear. Furthermore, were there any variations according to location?
Under informed consent, you refer to it as a ‘tool’. Although one respondent does discuss it as a
‘tool’, it is a process. Moreover, in thinking of it only as a ‘tool’ presumably to inform’, one
downplays the real issue, i.e., obtaining authentic consent. Informing is just one of the ingredients
of informed consent. Being a process implies something developing over time, not
instantaneously.
Had the other groups any perceptions on informed consent as they were asked about it?
Considering the questions asked about informed consent, was there any other than it being an
important process that was discussed?
In ‘decision making, recruitment and consent taking’, you refer to ‘most participants’ and ‘they’. 
Again, here it is important to indicate which group you are referring to, and if there are differences.
Factors affecting recruitment to research: would females not be comfortable being interviewed by
any stranger, or just a male stranger? Spelling error on ‘sample type sought’.
Previous research experience: does this mean that those with no previous exposure to research
had sorcery concerns? Are some factors more important than others?
The patient groups were not asked about incidental findings. Why is this?
Discussion
The 4  paragraph is confusing and raises a number of issues. You are stating that participants want to
know basic information, but then state that information sheets and consent forms should have much more
information. The discussion does not correlate with what has been stated in the results. How does this link
to ‘genuine’ informed consent. Indeed, what is the difference between ‘genuine informed consent’ and
‘informed consent’. The term ‘authentic’ informed consent may be more appropriate.
Incidental findings is a challenging topic and one that needs to be addressed in this context. Some
reflection on the views expressed in these findings must be discussed. As the paper stands, the issuer
regarding incidental findings is almost an afterthought, despite it appearing to be of importance in the
introduction.
Research should generally benefit the society/individuals who participate. How would this society benefit?
How was feedback provided to the participants, if at all?
Retention of samples/banking: This may also be an area of great concern. It is troubling that respondents
may not have a clear understanding of what this means and the importance be down played, since it is
‘only’ buccal swabs we’re dealing with. What measures should be taken to improve this
misunderstanding?
Discussion on the REA, its use and limitations should be expanded.
Those 20 page hardly comprehensible consent forms are problematic in all settings, more so in this
context. Discuss methods of obviating this…e.g., a shortened say 2 page summary dealing with the main
issues, in plain language.
Is the work clearly and accurately presented and does it cite the current literature?
Yes
Is the study design appropriate and is the work technically sound?
th
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 Is the study design appropriate and is the work technically sound?
Yes
Are sufficient details of methods and analysis provided to allow replication by others?
Partly
If applicable, is the statistical analysis and its interpretation appropriate?
Yes
Are all the source data underlying the results available to ensure full reproducibility?
Yes
Are the conclusions drawn adequately supported by the results?
Partly
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 Angela Fenwick
Clinical Ethics and Law, Southampton General Hospital, University of Southampton, Southampton, UK
This paper describes a study using the Rapid Ethical Appraisal (REA) method to identify potential barriers
to the consent process in preparation for a following genetic study on podoconiosis. The findings are
potentially interesting but the paper needs some reworking before publication. 
 
Title: The title does not reflect the contents of the paper and I would re-phase to indicate you used REA to
identify the contextual factors/issues relevant for the podoconiosis study and to reflect the conclusion in
your abstract. It currently looks like you are going to discuss the method of REA rather than apply it.   
 
Abstract:
The first sentence of your abstract is unclear and needs clarification: whose knowledge? And what
do they need to know about research ethics to consent to a study?
In the results section you appear to confuse the process of consent with evidence of consent which
is repeated later in the paper. Do you mean that some participants preferred their consent to be
recorded on a written consent form? If you clarify this in the body of your text you could come back
to rephrase this sentence in the abstract. 
You state that the ‘type of biological sample sought and gender’ were the two most important
factors affecting the recruitment process’ but I assume you mean the two most important factors
that the participants identified for the podoconiois study? These two are just listed in a table in your
results section which seems inconsistent with the importance you attach to them.
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Introduction
This is brief and some complex issues are dealt with rather superficially; for example in relation to
therapeutic misconception: might the distinction between clinical care and research be less binary
in some contexts, for example participating in research may give you a diagnosis (or a risk
prediction) which you could then follow up. Similarly with autonomous decision making: to what
extent do people really make decisions on their own? 
I am not clear about the extent to which the use of REA is faster or cheaper than other ‘tools’
(which might be?) given the number of interviews and focus groups you conducted etc. Can you
clarify? 
 
Methods
This needs expanding to include: some justification for your sample and sample size; how you
decided whether to use a focus group or interview; how you dealt with these two different data sets
during analysis. 
You mention the prevalence of podoconiosis for over 15yrs but you only interviewed people over
18 so you need to give an explanation of why this was the case. 
Under data analysis you say you used a conceptual framework described in previous studies and,
whilst I don't think you need to go into lots of detail about this, I should not have to look up other
studies to ascertain what you did. A brief summary would suffice.  
 
Results
In para 2 your themes should relate to your following headings more specifically. In general terms,
this section would benefit from a re-organization. You move from present to past tense in this
section on occasion: a general rule is that when you are reporting what participants felt, said etc
you should use the past tense. 
Perceptions of heath research: I am unclear whether you were asking participants about healthcare
research in general or for your particular podoconiosis study: either way this needs clarifying.
Without understanding this it is difficult to interpret your narrative (this is the case elsewhere also
so a general clarification would help); for eg, the first quote indicates that research gives health
status which may well be the case if a participant gets a diagnosis from their participation in
research (as I indicated above), but this may not be the case in your particular study.  (See also
reference to this in the 2  para of your discussion). The rest of this section reads rather clumsily
with some repeated information and could do with streamlining. 
Perceptions on informed consent for health research: this section is rather brief given the
complexity of the concept. Could it be joined with another section? Is consent a ‘tool’? Isn’t it a
process? The 2  quote relates to coercion and you could have highlighted this as it reflects more
depth of thinking than your narrative indicates.  
Preparation of consent form and information sheet: does the first sentence relate to the forms or to
the wider process of consent which includes verbal explanation? This needs clarifying up-front -
and in your second para - as from the quotes I would infer it was the latter, but this doesn't match
your theme heading. The quote on confidentiality in particular seems to referring to issues inherent
in the process rather than what they want included in information sheets.
Approaching potential study participants: the title isn’t clear and isn’t clarified in your first sentence
where ‘potential’ is not indicated. Are you referring to whom to approach first about a study (ie
people who may not actually be the potential study participants but who act as
gatekeepers/facilitators)?
Information provision: the distinction between this theme and ‘Preparation of consent form and
nd
nd
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 Information provision: the distinction between this theme and ‘Preparation of consent form and
information sheet’ isn’t clear to me. Are you referring here to information about podoconiosis?
Decision making, recruitment and consent taking: there is lots wrapped up in this heading and, as I
indicated above, I think your table needs an accompanying narrative if it includes the 2 factors you
consider most important. The first para is confusing and needs re-writing. In relation to the para
that begins: ‘We found mixed views…’: I don't understand why this wouldn't be under the theme,
‘Preparation of consent form and information sheet’. 
Return of incidental findings: this seems a huge topic to take on in such a brief way in this paper
and I would suggest considering removing it as, as it stands, does not really tell me anything
useful; and I have no idea whether the podoconiosis study would involve the return of IFs from
what you have written. Furthermore I am not clear why you didn't ask patient and community
members questions about Ifs. If you removed this theme you could expand on gender and sample
type etc., if you are short of words.  
 
Discussion
In the first sentence you refer to ‘genuine informed consent’ which is a tautology. If consent is what
you outline in your first paragraph then it doesn't need additional adjectives (you use it in your
abstract also). In the 4  para you say: ‘it is important to cover  aspects of the research to helpall 
participants reach an informed decision’, and ‘a   explanation’ is necessary but what doesthorough
this mean in this context? How did your research help you understand what was appropriate? 
If you re-organise your themes and take into account the issues raised above, then your discussion
will be strengthened.
Can you say more about what you wouldn't have known for the podoconiosis study if you had just
relied on previous REA studies in Ethiopia? I would like a summary of what you took forward into
the podoconiosis study. 
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Are sufficient details of methods and analysis provided to allow replication by others?
Partly
If applicable, is the statistical analysis and its interpretation appropriate?
Not applicable
Are all the source data underlying the results available to ensure full reproducibility?
Yes
Are the conclusions drawn adequately supported by the results?
Partly
 No competing interests were disclosed.Competing Interests:
Referee Expertise: Ethical issues in genetic and genomic medicine; qualitative research methodology
I have read this submission. I believe that I have an appropriate level of expertise to confirm that
th
Page 15 of 19
Wellcome Open Research 2017, 2:99 Last updated: 07 DEC 2017
 I have read this submission. I believe that I have an appropriate level of expertise to confirm that
it is of an acceptable scientific standard, however I have significant reservations, as outlined
above.
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Overall
This is an interesting paper and we thank you for giving us the opportunity to review it and provide you
with some feedback that may improve the manuscript. Our most important point is to challenge you to
integrate in the Discussion section some critical feedback on the limits of the REA method, or at least
some reflection on whether and when REAs should be conducted if similar other REAs have already been
conducted on the same diseases and/or the same scientific methodologies, albeit in different populations.
Specifically, we would challenge you to consider whether the REA you report in this study yielded new
information that led to the design of a ‘better’ (more locally attuned) consent process than would have
been designed without the REA having been conducted (drawing on the results of other published REA
studies conducted in Ethiopia). Early in the manuscript, you hypothesise that the linguistic and cultural
variation in this part of Ethiopia justified conducting another REA – did you find that hypothesis to be true
(and please give concrete examples)? And if so, what is the implication for the design of future genomic
studies?
 
Below, we give you some feedback specifically on each of the sections of the manuscript. Some of these
are mere suggestions that would enrich your discussion and description; others are more critical of the
way you present your work. We hope that these suggestions are useful to you and look forward to the
next iteration of this manuscript.
 
Introduction
In paragraph 2 on Pg1 you refer to ‘therapeutic misconception’ and we would suggest that you add
a reference to ‘diagnostic misconception’ there also. This term is now used in genomics research
to describe the misconception by healthy controls that they are participating in a public screening
endeavour;
In paragraph 3 you mention one particular challenge to genomics research that has implications for
the consent process – namely, incidental findings. Yet the design of genomics research harbours a
number of features that impact on the consent process. In this paragraph, it would be good to
reference one or two sources that outline the ways in which features of genomics research may
impact on the consent process, and then also explain why in the Introduction you pick out the
possibility for generating ‘incidental findings’ as a particular issue.
We would suggest that the authors change their use of the term ‘developing countries’ to the now
more commonly accepted ‘Lower and Middle Income’ countries or LMICs;
You introduce the REA method as a ‘recent’ method (pg1) but it’s not altogether recent anymore.
Perhaps you could rather say ‘one tool that has been applied successfully to ensure the adaptation
of consent processes to local and cultural sensitivities is XYZ’.
 
Study design and participants:
Add a sentence or two describing the group of “participants” referred to as Podoconiasis
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 Add a sentence or two describing the group of “participants” referred to as Podoconiasis
administrators. This is not very obvious compared to the other groups such as religious workers,
researchers, IRB members;
The FGDs were comprised of single-sex adults each containing 5 to 7 individuals. Maybe add a
few sentences explaining why FGDs were composed of single-sex adults only and not otherwise.  
 
Data Analysis
If the PI and co-investigators are authors of the paper, it may be better to use their initials as it has
been done in the other cases.
Under ‘data collection’ – were the interviews back-translated, or were the topic guides
back-translated? And if so, what was the purpose of back-translating the topic guides by an
independent person? (This is of course often done for informed consent to ensure the quality of the
translation, but topic guides are a different kind of material and it’s not immediately obvious that
these should also be ‘back-translated’ in the same way. It would be good to explain why you did
that)
 
Table 1
Maybe explain why there are differences in the methods used at the different sites. For example: Why
were FGDs done with patients at East Gojjam and not at East Wellegam. This is important because  the
authors argue that even though REAs have been previously used to explore ethical issues in Ethiopia, the
problems identified might not have been be applicable to other Ethiopian populations that differ in social
and community structure.
 
Results
Overall, it may be good to get more of the researchers’ interpretation of the quotes. For example,
what could explain why research participants associate health research with HIV testing and not
testing for other diseases prevalent in that area?
You describe in your results that people confused ‘research’ with police or criminal investigation,
but you only offer one quote by an administrator who describes that risk exists. It is an important
point though – it may impact on people’s voluntariness and ability to reject giving consent – and so
merits being drawn out a bit. Have you got any quotes from prospective participants in the genomic
study that illustrate this point? Could you perhaps give us a flavour of whether this was an
important theme in your data or not?
In your description of results, you sometimes describe all your interviewees as ‘participants’ and at
other times you only talk about subgroups in your dataset (‘fieldworkers’ and ‘IRB members’). This
is confusing, particularly when you shift focus in the article and it also only gives a very partial view
of your data. E.g. when speaking about ‘understanding of research’ you talk about community
members and patients, yet for ‘perceptions of IC’ you only talk about fieldworkers and IRB
members – but this is not altogether clear when reading the paper. Perhaps you could talk about
each stakeholder group for each of the themes you describe in the paper? 
Were Researchers/IRB members the same group of people? Where they interviewed as
researchers or as IRB members or both? This needs to be stated in the method.
 
Perceptions on health research
The following quote “Research is used to increase new knowledge, whereas diagnosis is to find
the disease.” (Patient 7, Gojjam) does not support the observation that patients did not understand
the difference between research and clinical care. Rather, it confirms that the participant knew that
diagnosis as part of routine care was different from research.
How did the perception on health research by the different groups vary and what may be the
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 How did the perception on health research by the different groups vary and what may be the
contributing factors.
 
Preparation of consent form and information sheet 
The quote below may be moved to the next section. This is because it speaks more on approaching
research participants than on the preparation of informed consent form and information sheet.
“Confidentiality should be secured but it is a very difficult issue since most often many people are
around…You may make an effort to keep people out of the hearing distance but in a village setting it is
often not easy. Then the idea of confidentiality may also be a bit different because people have most of
their private things in public. Is it not?" So, I think that is the most important thing, confidentiality.”
(Researcher/IRB member 3).
 
Decision-making, recruitment and consent taking
The authors state that some of the “participants” also said they reached a decision on their own if the
research benefits their health – further evidence that ‘therapeutic misconception’ is common in society.  A
quote from a research participant (patient) is needed to support this statement.
 
Discussion
A number of claims are made in the discussion section that have not been presented in the results
section. The discussion should reflect the results presented and new concepts should ideally not
be introduced in the discussion. For example:
Most participants residing in rural areas did not know the distinction between research and
health care and thought they were being screened to receive treatment rather than
participate in research. Maybe first describe the two study sites, e.g. whether they are rural
or urban. In the results section, provide quotes that support the claim that those in rural
areas did not support the distinction between research and health care;
In your discussion, I don’t think it is appropriate to reference the Nigerian polio vaccine example to
illustrate why CE is important in the context of health research – it is just one example and it’s from
a completely different research context & country. There are stronger ethical grounds that make
CE imperative and it would be more appropriate to draw on those.
We find the 5  paragraph of your discussion somewhat problematic. On the one hand, your data,
as presented in the paper, seems to argue that participants do not want detailed information about
the study but rather want information about the disease together with information about what will
happen to their samples. Yet in this paragraph you argue that ‘participants should really know’
certain things and if they don’t understand then more work should be done to explain these things
better. To us, this raises two questions, namely: 1) what was really in your data, and was there
perhaps a range of views that lead you to describe the kinds of information participants should
have and 2) how is the list that you describe informed by your data?
Is the work clearly and accurately presented and does it cite the current literature?
Yes
Is the study design appropriate and is the work technically sound?
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 Not applicable
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